Vir Biotechnology Gross Margin Growth & History (VIR)

Vir Biotechnology's gross margin was 99.96% for fiscal 2025.

View full Vir Biotechnology company overview

Vir Biotechnology annual gross margin history

Vir Biotechnology annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3199.96%+1.10 pp
20242024-12-3198.86%+2.07 pp
20232023-12-3196.79%+5.85 pp
20222022-12-3190.94%−3.04 pp
20212021-12-3193.99%−6.01 pp
20202020-12-31100.00%0.00 pp
20192019-12-31100.00%

Vir Biotechnology gross margin trends

Over the last five fiscal years, Vir Biotechnology's gross margin decreased from 100.00% to 99.96%, a change of −0.04 percentage points. The latest reported quarter, Q2 2026, shows 100.00%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Vir Biotechnology source filings ↗

Community posts

It’s quiet here.

No posts about VIR yet. Start the conversation.

Write the first post